MedTrace Logo

Lidocaine-Prilocaine Cream (EMLA) Topical Application Versus Wound Infiltration With Lidocaine After Cesarean Section

NCT02549105 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2015-09-15

No results posted yet for this study

Summary

A Comparison Between Lidocaine-Prilocaine Cream (EMLA) Application And wound Infiltration with Lidocaine For Post Caesarean Section Pain Relief : A Randomized Controlled Trial.

Conditions

  • Post Operative Pain

Interventions

DRUG

EMLA CREAM 5 mg

EMLA CREAM APPLICATION FOR WOUND AFTER CS

DRUG

LIDOCAINE 1 %

LIDOCAINE 1 % INFILTERATION FOR WOUND AND ASSESSMENT OF PAIN IN FIRST 6 HOURS

Sponsors & Collaborators

  • Ain Shams University

    collaborator OTHER

  • Ain Shams Maternity Hospital

    lead OTHER

Principal Investigators

  • MAGED R ABO SAEDA, MD · AIN SHAMS MATERNAL HOSPITAL

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02549105 on ClinicalTrials.gov